SYNDEO Medical Launches SATURN™ Inflation Device

ZAVENTEM, Belgium — FOR IMMEDIATE RELEASE

6 June 2023 – SYNDEO Medical, a division of MDev BV, a global leader in the design and development of fully integrated custom procedural solution products, is pleased to introduce the SATURN™ Inflation Device. This innovative platform brings a new level of innovation, versatility, and selection to interventional physicians worldwide. With its seamless integration into SYNDEOPack™ interventional procedure packs, the SATURN™ Inflation Device provides healthcare professionals with a comprehensive solution that combines the benefits of both products into a single platform.

"We believe that by incorporating the SATURN™ Inflation Device into our SYNDEOPack™ interventional procedure pack portfolio, we streamline the procurement process and eliminate the need for healthcare providers to source inflation devices separately, saving them valuable time, effort, and cost," stated Justin J. Lampropoulos, CEO of SYNDEO Medical. "This strategic integration of the SATURN™ Inflation Device into the SYNDEOPack™ ensures a seamless and convenient solution for healthcare professionals, allowing them to focus on delivering high-quality care without the complexity of managing multiple product acquisitions."

The SATURN™ Inflation Device is CE marked, an FDA exempt device, and available in a variety of configurations, including options for 30 and 40 atmospheres, as well as circular and T-handle designs, catering to the diverse needs of healthcare professionals. This selection ensures optimal compatibility and performance in various interventional procedures, empowering healthcare providers with flexibility and versatility.

For more information on incorporating the SATURN™ Inflation Device into your interventional procedure pack, please contact SYNDEO Medical or visit syndeomedical.be.